United States. Government Accountability Office & ProQuest (Firm). (2006). New drug development: Science, business, regulatory, and intellectual property issues cited as hampering drug development efforts : report to congressional requesters. GAO.
Chicago Style (17th ed.) CitationUnited States. Government Accountability Office and ProQuest (Firm). New Drug Development: Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts : Report to Congressional Requesters. Washington, D.C.: GAO, 2006.
MLA (9th ed.) CitationUnited States. Government Accountability Office and ProQuest (Firm). New Drug Development: Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts : Report to Congressional Requesters. GAO, 2006.